Recent Media Publications
News, press, and media resources for Celtic Biotech and our Crotoxin-derived pipeline.
February 2026
Dr. Dorothy Bray Addresses Challenges in Designing Phase I Oncology Studies at CTIP 2026
Dorothy H Bray, Director at Celtic Biotech Ltd, took the stage at CTIP to discuss the unique challenges of designing Phase I studies in oncology. Dr. Bray provided a masterclass on the strategic precision required in early-stage cancer research.
December 2025
Results in Early-Phase Clinical Trials Suggest Snake Venom as a Potential Cancer Therapy
Irish biotech plans to advance crotoxin, a protein in rattlesnake venom, for the treatment of cancer following results in early-phase clinical trials. Early studies from MD Anderson and NCI confirmed therapeutic activity.
November 2025
Celebrating Biotech Company of the Year 2025!
Awarded Biotech Company of the Year at the Pharma Industry Awards 2025. Celtic also made two other finalists categories. Judges: “They are a true testament of skill, passion and perseverance.”
November 2025
Biopharma Company of the Year shortlist – Pharma Industry Awards 2025
Celtic Biotech shortlisted alongside AbbVie, Amgen and Takeda for Biopharma Company of the Year.
October 2025
Celtic Biotecah’s Clinical Team Presents Phase I Crotoxin Trial Data at ESMO 2025
Data from the ongoing Phase I trial of Crotoxin in patients with advanced cancer at ESMO 2025 in Berlin. Intra-patient dose escalation was safe and feasible, with a trend toward clinical benefit.
September 2025
Ireland’s pharma sector is world class – why don’t we have a Novo Nordisk?
Feature on Ireland’s pharma sector and the need for a home-grown pharma champion.
July 2025
21 Irish MedTech start-ups to watch in 2026
With strong roots in Ireland’s collaborative innovation ecosystem, these medtech pioneers are building the future of medicine.
June 2025
Where does Celtic Biotech get its venom?
Jim and Kristen at Kentucky Reptile Zoo manage our proprietary colony of Crotalus Durissus. See how they extract the precious venom.
May 2025
Celtic Biotech selected by EIC for Dublin Tech Summit 2025
Celtic Biotech and 3 other EIC Accelerators were selected by the European Innovation Council to exhibit and present at the EIC stand at Dublin Tech Summit 2025.
May 2025
Dr. Dorothy Bray leads panel on Novel Peptide Therapeutics at NextGen Biomed 2025
Dr. Bray discussed Celtic Biotech’s clinical drug pipeline and presented our clinical experiences with lead candidate CB-24.
October 2024
Developing a First-in-Class Biologic Targeting the Nicotinic Receptor on Cancer Cells
CB-24 represents the world’s first biologic anti-cancer monotherapy. Currently in Phase I; initial primary disease target will be non-small cell lung cancer. The drug by-passes healthy cells leaving patients with mild or no side effects.
May 2025
EIC USA Soft-landing programme
15 of the most innovative EIC-backed companies on health and life sciences were selected for the EIC USA Soft-landing programme. Soft-landing week in San Francisco and Silicon Valley 19–24 May 2024.
March 2024
Top 100 Most Ambitious Companies in Ireland
Spark Crowdfunding’s annual poll of early-stage businesses. Celtic Biotech featured in the Top 100.
February 2024
Innovating Cancer Treatment: Celtic Biotech’s Venom-Derived Breakthroughs | IBTimes
International Business Times feature on Celtic Biotech’s venom-derived cancer therapeutics.
December 2023
Top Therapeutics Companies in Europe
Celtic Biotech: Pioneering Breakthrough remedies for Terminal Health Conditions.
November 2023
EIT Catapult Top 10 Life Science Companies (Top 30)
Celtic Biotech selected in EIT Health Catapult Top 30 life science companies.
September 2023
This biotech is turning snake venom crotoxin into a cancer therapy
Meet the startup developing novel cancer therapies from snake venom crotoxin.
September 2023
Six Ireland-UK start-ups selected for EIT Health Catapult 2023-24 semi-finals
Six high-potential start-ups have been selected as semi-finalists in the EIT Health Catapult 2023-24 competition. They will join 24 other European companies for mentorship and training.
August 2023
Celtic Biotech: Developing novel cancer treatments from snake venom
Brothers Paul and John Reid have assembled an international team of experts in biotech, pharma and business to help save the lives of lung cancer patients.
July 2023
Celtic Biotech reaches EIT Catapult accelerator semi-finals
In further recognition of its potential, Celtic Biotech reached the semi-finals of the prestigious EIT Catapult accelerator programme.
June 2023
€18m funding win for four Enterprise Ireland client companies in Horizon Europe EIC Accelerator
Enterprise Ireland announcement of EIC Accelerator funding for Celtic Biotech and three other client companies.
June 2023
Four Innovative Irish Medical Start-Ups Granted €18m In EU Funding
Business Plus | Ireland: Four Irish medical start-ups granted €18m in EU funding.